NCT04761822 2025-08-12
SARS
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
National Institute of Allergy and Infectious Diseases (NIAID)
Masonic Cancer Center, University of Minnesota
BioAegis Therapeutics Inc.
Vascular Biogenics Ltd. operating as VBL Therapeutics
Centre Leon Berard
Nantes University Hospital